BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 17062843)

  • 21. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.
    Domingo P; Cabeza MC; Pruvost A; Salazar J; Gutierrez Mdel M; Mateo MG; Domingo JC; Fernandez I; Villarroya F; Muñoz J; Vidal F; Baiget M
    Clin Infect Dis; 2010 Apr; 50(7):1033-40. PubMed ID: 20192724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resting energy expenditure and body composition of Labrador Retrievers fed high fat and low fat diets.
    Yoo S; Ramsey JJ; Havel PJ; Jones PG; Fascetti AJ
    J Anim Physiol Anim Nutr (Berl); 2006 Jun; 90(5-6):185-91. PubMed ID: 16684138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA depletion and respiratory chain enzyme deficiencies are present in peripheral blood mononuclear cells of HIV-infected patients with HAART-related lipodystrophy.
    Miró O; López S; Pedrol E; Rodríguez-Santiago B; Martínez E; Soler A; Milinkovic A; Casademont J; Nunes V; Gatell JM; Cardellach F
    Antivir Ther; 2003 Aug; 8(4):333-8. PubMed ID: 14526764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management trends. Resting energy expenditure in the HAART era.
    Shevitz AH
    AIDS Read; 2000 Sep; 10(9):539-44; quiz 557-8. PubMed ID: 11019449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV lipodystrophy and its metabolic consequences: implications for clinical practice.
    Wierzbicki AS; Purdon SD; Hardman TC; Kulasegaram R; Peters BS
    Curr Med Res Opin; 2008 Mar; 24(3):609-24. PubMed ID: 18208641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Korsheninnikova E; Funahashi T; Matsuzawa Y; Nyman T; Yki-Järvinen H
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1907-10. PubMed ID: 12679491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resting energy expenditure and its determinants in hemodialysis patients.
    Kamimura MA; Draibe SA; Avesani CM; Canziani ME; Colugnati FA; Cuppari L
    Eur J Clin Nutr; 2007 Mar; 61(3):362-7. PubMed ID: 16943847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic basis of HIV-lipodystrophy syndrome.
    Sekhar RV; Jahoor F; White AC; Pownall HJ; Visnegarwala F; Rodriguez-Barradas MC; Sharma M; Reeds PJ; Balasubramanyam A
    Am J Physiol Endocrinol Metab; 2002 Aug; 283(2):E332-7. PubMed ID: 12110539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy.
    Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
    AIDS; 2002 Nov; 16(16):2183-93. PubMed ID: 12409740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation.
    Montaurier C; Morio B; Bannier S; Derost P; Arnaud P; Brandolini-Bunlon M; Giraudet C; Boirie Y; Durif F
    Brain; 2007 Jul; 130(Pt 7):1808-18. PubMed ID: 17535833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrastructural features of highly active antiretroviral therapy-associated partial lipodystrophy.
    Lloreta J; Domingo P; Pujol RM; Arroyo JA; Baixeras N; Matias-Guiu X; Gilaberte M; Sambeat MA; Serrano S
    Virchows Arch; 2002 Dec; 441(6):599-604. PubMed ID: 12461618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.
    Andersen O; Eugen-Olsen J; Kofoed K; Iversen J; Haugaard SB
    J Med Virol; 2008 Feb; 80(2):209-16. PubMed ID: 18098145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher fasting serum insulin is associated with increased resting energy expenditure in nondiabetic schizophrenia patients.
    Fan X; Anderson EJ; Copeland PM; Borba CP; Nguyen DD; Freudenreich O; Goff DC; Henderson DC
    Biol Psychiatry; 2006 Dec; 60(12):1372-7. PubMed ID: 16920075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 infection alters gene expression in adipose tissue, which contributes to HIV- 1/HAART-associated lipodystrophy.
    Giralt M; Domingo P; Guallar JP; Rodriguez de la Concepción ML; Alegre M; Domingo JC; Villarroya F
    Antivir Ther; 2006; 11(6):729-40. PubMed ID: 17310817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution.
    Andersen O; Pedersen SB; Svenstrup B; Hansen BR; Paulsen SK; Rathje GS; Richelsen B; Nielsen JO; Madsbad S; Iversen J; Haugaard SB
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):250-8. PubMed ID: 17524033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with body-fat changes in prevalent peritoneal dialysis patients.
    Vasselai P; Kamimura MA; Bazanelli AP; Pupim LB; Avesani CM; da Mota Ribeiro FS; Manfredi SR; Draibe SA; Cuppari L
    J Ren Nutr; 2008 Jul; 18(4):363-9. PubMed ID: 18558301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of dual-energy X-ray absorptiometry machines for measuring fat distribution changes of HIV-associated lipodystrophy.
    Yang Y; Zhu WD; Paton NI
    Antivir Ther; 2004 Oct; 9(5):771-8. PubMed ID: 15535415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.